1. Sex-dependent complex association of TPH2 with multiple dimensions of ADHD.
- Author
-
Fageera, Weam, Sengupta, Sarojini M., Fortier, Marie-Ève, Grizenko, Natalie, Babienco, Svetlana, Labbe, Aurelie, and Joober, Ridha
- Subjects
- *
ATTENTION-deficit hyperactivity disorder , *TRYPTOPHAN hydroxylase , *BEHAVIORAL assessment , *CROSSOVER trials , *METHYLPHENIDATE - Abstract
Tryptophan hydroxylase 2 (TPH2) is a key enzyme in the biosynthesis of serotonin in the brain. This study aims to investigate the role of a functional variant in TPH2 (rs17110747) in the pathophysiology of ADHD. This variant has been implicated in mood disorders in recent meta-analysis. This study uses a comprehensive approach that combines association testing and pharmaco-dynamic evaluation of behaviour, in a large sample of children with ADHD (n = 570). The association between various ADHD relevant traits and rs17110747 was analyzed using family-based association tests (FBAT). Children were assessed by parents, teachers and research staff under three experimental conditions (EC): baseline, placebo, and methylphenidate using a double-blind placebo-controlled crossover trial. FBAT analysis conducted in a sample stratified based on sex of the proband, showed that there was a highly significant overtransmission of the G allele from parents to affected girls. In addition, significant association with several behavioral and cognitive dimensions of ADHD was observed only when the proband was female. Further, girls with the G/G genotype (rs17110747) had greater response to placebo when evaluated by parents. These results suggest that there may be a complex association of TPH2 in the etiology of ADHD, with a sex-specific effect. • Family-based association tests show specific findings with TPH2 and girls with ADHD. • Sex-specific effect is observed with behaviour and cognitive dimensions. • Differential association also observed with treatment response in girls. • Appears that there may be different etiological pathways in girls with ADHD. • Results may inform sex-specific pharmacological interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF